Amgen
AMGN
435.39
+10.45
+2.46%
Amgen
US · AMGN
#91 by market cap
Listed 1970
435.39
+10.45
+2.46%
Live - 5344 symbols - heartbeat 51s ago
· 2026-10-20 11:00
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions increased by 2 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 83.90% -0.06pp
- Institutions
- 3,570 +2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund70.03%
Public Company6.21%
Private Company2.16%
Government Pension Fund1.95%
Hedge Fund1.25%
Sovereign Wealth Fund1.10%
Family Office/Trust0.56%
Insurance Company0.34%
Individual/Insider0.17%
Other16.22%
Top holders as of 2026-06-30
BlackRock
9.13% · 49.36M sh
Vanguard Capital Management, LLC
7.09% · 38.33M sh
Capital Research
6.92% · 37.43M sh
State Street Global Advisors
5.65% · 30.56M sh
Geode Capital Management, LLC
2.90% · 15.70M sh
Other
68.30%
Invesco Capital Management LLC
2.87% · 15.51M sh
Charles Schwab Investment Management
2.78% · 15.04M sh
Vanguard Portfolio Management, LLC
2.75% · 14.85M sh
Morgan Stanley
1.68% · 9.06M sh
UBS Asset Management
1.61% · 8.70M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 21 buys · 27 sells
| Name | Role | Stake |
|---|---|---|
| Robert Bradway | Chairperson & CEO | 0.11% |
| Esteban Santos | Officer | 0.01% |
| Murdo Gordon | Executive VP of Global Commercial Operations | 0.01% |
| Peter Griffith | Chief Financial Officer | 0.01% |
| David Reese | Officer | 0.01% |
| Jonathan Graham | General Counsel | 0.01% |
| Gregory Garland | Independent Director | 0.00% |
| Derek Miller | Officer | 0.00% |
| Wanda Austin | Independent Director | 0.00% |
| Robert Eckert | Lead Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-31 | Thomas J. Dittrich | Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-08-12 | Rachna Khosla | Officer | Derivative Exercise and Sale | -1,252 | $162.60–416.43 |
| 2026-08-10 | Rachna Khosla | Officer | Open Market Disposition | -2,000 | $412.57 |
| 2026-08-06 | Charles Holley | Independent Director | Other Acquisition | +103 | -- |
| 2026-08-06 | Michael Drake | Independent Director | Other Acquisition | +63 | -- |
| 2026-08-06 | S. Ishrak | Independent Director | Other Acquisition | +85 | -- |
| 2026-08-06 | Matthew Busch | Chief Accounting Officer & VP of Finance | Other Acquisition | +730 | -- |
| 2026-08-05 | Nancy Grygiel | Senior VP of Worldwide Compliance & Business Ethics and Chief Compliance Officer | Intent to Sell (Form 144) | -2,970 | $402.00 |
| 2026-08-05 | Nancy Grygiel | Senior VP of Worldwide Compliance & Business Ethics and Chief Compliance Officer | Derivative Exercise and Sale | -2,970 | $177.31–402.16 |
| 2026-08-05 | Derek Miller | Officer | Derivative Exercise and Sale | -3,890 | $162.60–402.54 |
| 2026-05-18 | Robert Eckert | Lead Independent Director | Other Acquisition | +665 | -- |
| 2026-05-18 | Amy Miles | Independent Director | Other Acquisition | +665 | -- |
| 2026-05-18 | Charles Holley | Independent Director | Other Acquisition | +665 | -- |
| 2026-05-18 | Gregory Garland | Independent Director | Other Acquisition | +665 | -- |
| 2026-05-18 | Ellen Kullman | Independent Director | Other Acquisition | +665 | -- |
| 2026-05-18 | Brian Druker | Independent Director | Other Acquisition | +665 | -- |
| 2026-05-18 | Tyler Jacks | Independent Director | Other Acquisition | +665 | -- |
| 2026-05-18 | Michael Drake | Independent Director | Other Acquisition | +665 | -- |
| 2026-05-18 | Wanda Austin | Independent Director | Other Acquisition | +665 | -- |
| 2026-05-18 | S. Ishrak | Independent Director | Other Acquisition | +665 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-20 11:00:10 · For reference only, not investment advice and not tailored to your situation.
Amgen discussion 0 comments